...
Contact Now

CAR-T Therapy (Solid Tumor)

  • Home
  • CAR-T Therapy (Solid Tumor)

CAR-T Therapy (Solid Tumor) Therapy

CAR-T Therapy, short for Chimeric Antigen Receptor T-Cell Immunotherapy, is an advanced gene therapy method that involves genetically modifying a patient’s own T cells to target and destroy cancer cells. Unlike traditional medications, CAR-T therapy is tailored to each patient and requires collecting T cells from the patient’s blood before reinfusing them back into the body after genetic engineering.

CAR-T Therapy (Solid Tumor) Therapy is used for

  • Treating relapsed or refractory acute lymphoblastic leukemia
  • Managing certain types of non-Hodgkin lymphoma
  • Treating multiple myeloma in resistant cases
  • Targeting B-cell malignancies unresponsive to standard treatments
  • Being studied for potential use in solid tumors

How CAR-T Therapy (Solid Tumor) Therapy works

  • T-Cell Collection: T cells are taken from the patient’s blood using leukapheresis (about 4 hours)
  • Genetic Modification: Collected T cells are engineered to target cancer cells
  • Expansion: Modified T cells are multiplied in the lab for 2–3 weeks
  • Infusion: Engineered T cells are given back to the patient via IV
  • Duration & Side Effects: The process takes 4–6 weeks; CRS is the most common side effect

Advantages of CD7 CAR-T Therapy

  • High Effectiveness: Can achieve remission even in advanced or resistant cancers
  • Personalized Treatment: Uses the patient’s own T cells for therapy
  • Long-Term Benefit: Provides durable responses in many patients
  • Single Treatment: Often requires just one infusion instead of ongoing therapy
  • Expanding Potential: Research shows promise beyond blood cancers

Our Advantages

  • Targeted Tumor Attack: CAR-T cells are engineered to recognize and destroy solid tumor cells
  • Resistant Cancer Treatment: Provides an option for patients whose tumors don’t respond to standard therapies
  • Broader Cancer Coverage: Expands immunotherapy use beyond blood cancers into solid tumors
  • Personalized Care: Each therapy is designed using the patient’s own T cells for precise action
  • Future Potential: Ongoing research continues to explore wider applications in solid tumor types
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.